Vertex Pharmaceuticals Revenue by Segment

History

Date	Trikafta and Kaftrio	Kalydeco	Orkambi	Symdeko and Semkevi
Jun 30, 2024	9.50B	475.50M	326.00M	123.00M
Mar 31, 2024	9.29B	499.20M	392.60M	129.50M
Dec 31, 2023	8.94B	525.80M	475.80M	134.30M
Sep 30, 2023	8.63B	539.20M	501.10M	145.80M
Jun 30, 2023	8.37B	553.20M	510.70M	180.00M
Mar 31, 2023	8.02B	569.30M	547.30M	226.10M
Dec 31, 2022	7.69B	592.30M	585.60M	269.30M
Sep 30, 2022	7.36B	636.90M	685.00M	360.10M
Jun 30, 2022	6.90B	684.20M	771.60M	420.40M
Mar 31, 2022	6.27B	725.40M	839.66M	467.53M
Dec 31, 2021	5.70B	756.86M	881.08M	542.31M
Sep 30, 2021	5.10B	776.62M	892.06M	580.54M
Jun 30, 2021	4.50B	802.90M	907.50M	628.60M
Mar 31, 2021	4.16B	845.08M	1.12B	832.91M
Dec 31, 2020	3.86B	900.62M	1.19B	1.08B
Sep 30, 2020	3.19B	959.67M	1.27B	1.27B
Jun 30, 2020	2.23B	991.06M	1.33B	1.42B
Mar 31, 2020	1.32B	755.48M	906.16M	1.09B
Dec 31, 2019	420.11M	506.08M	609.45M	682.11M

Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.